Top Medical Device Marketing Agencies for 2026

Last Updated: October 28, 2026

By Shai Reichert, Co-Founder of XDS

Finding the right marketing partner for a medical device launch means more than picking an agency with healthcare experience. You need a team that understands FDA guidelines, speaks the language of HCPs and procurement committees, and knows how to build campaigns that work across digital and traditional channels.

This guide compares eight medical device marketing agencies for 2026 on regulatory expertise, omnichannel capabilities and track record with US market launches. Whether you're preparing for FDA clearance or scaling an established device portfolio, you'll find an agency that fits your goals. If you want a broader frame for how to think about agency selection, our guide to choosing a healthcare marketing agency is the right starting point.

Quick guide: 8 medical device marketing agencies for 2026

XDS, the studio that publishes this blog, is listed first. The rest appear in no particular order.

1. The Experience Design Studio (XDS): Full-stack medtech agency with regulatory content and AI-driven strategy
2. Podymos: UK-based agency with structured launch frameworks for medical devices
3. MedTech Momentum: Device-only agency that works as an outsourced marketing department
4. Supreme Group (Supreme Optimization and Clarity Quest): Private equity-backed life science marketing group with SEO and paid media focus
5. EVERSANA INTOUCH: Large-scale commercialization support for pharma and medtech
6. Fingerpaint Group: Creative services across pharmaceutical and device categories
7. Real Chemistry: Data-driven healthcare network with global reach
8. Icovy: Boutique medtech agency focused on startups and emerging devices

Short on time? Jump to the comparison table →

How we chose these medical device marketing agencies

Selecting a marketing partner for a regulated product requires careful evaluation. We reviewed dozens of agencies and narrowed the list based on criteria that matter most to medtech marketing leaders preparing for US launches. For the deeper strategic context behind these criteria, see our complete medical device marketing strategy guide.

• Regulatory content expertise: Can the agency create FDA-ready promotional materials and navigate OPDP submission requirements?
• US market launch experience: Has the agency successfully supported device approvals and market entries in the United States?
• Omnichannel capabilities: Does the agency offer integrated campaigns across digital, congress marketing, and sales enablement?
• HCP and patient engagement: Can the agency build campaigns that resonate with both clinical decision-makers and patients?
• CRM and marketing automation: Does the agency help you track and nurture leads through complex buying cycles?
• Measurable outcomes: Does the agency tie marketing activities to pipeline growth, qualified leads, and revenue?

We include ourselves on this list. You should weigh that accordingly, and the pros and cons below are written to be useful rather than flattering.

The 8 medical device marketing agencies for 2026

1. XDS: Full-stack support for US device launches

XDS is a full-stack life science marketing agency that combines strategy, design, engineering, and analytics under one roof. For medical device companies preparing for US market entry, the team covers brand positioning through digital activation and performance measurement.

The focus is on AI-driven content structuring and regulatory-ready messaging. Every asset needs to meet FDA promotional guidelines while still engaging HCPs and procurement teams. Our perspective on practical AI in regulated healthcare covers how this works in practice.

Past work includes brand and digital programs for Shockwave Medical, across cardiology, oncology, ENT devices, and digital health platforms. In hypertension, that includes branding ReCor Medical's hypertension therapy, from brand strategy and messaging to the company's first HCP and patient brochures.

XDS capabilities

• Regulatory content development: Promotional materials structured for FDA compliance, reducing back-and-forth during medical-legal review. Our breakdown of fair balance rules shows the level of detail involved.
• AI-powered content strategy: AI tools that speed up content production while keeping brand and regulatory consistency across touchpoints.
• Omnichannel campaign execution: Integrated programs across web, email, paid media, and congress marketing.
• CRM and marketing automation: HubSpot implementation and sales enablement tools to track leads from first touch through conversion. If CRM choice is on the table, see our HubSpot vs. Salesforce for healthcare comparison.
• User experience design: Device websites and digital platforms designed for both clinical audiences and patients, with accessibility built in. Our UX design in healthcare marketing primer lays out the principles.
• Analytics and measurement: Reporting that connects marketing activity to pipeline and commercial outcomes, anchored in a healthcare-specific attribution model.

XDS pros and cons

Pros:

• Full-stack capabilities reduce the need to coordinate multiple agency partners
• Depth in AI-driven content structuring for medtech and biotech brands
• Experience with US medical device launches and FDA-regulated content

Cons:

• Smaller team than global holding company networks, though this often means more senior attention on accounts
• Remote-first model may require adjustment if you prefer frequent in-person workshops

2. Podymos: Structured launch frameworks for medical devices

Podymos focuses exclusively on medical device marketing, with a methodology built around structured launch planning. The agency recommends starting nine to twelve months before approval to build messaging, content, and sales materials in time for market entry.

The team works with companies across cardiology, surgical robotics, and ophthalmic devices. Their approach emphasizes educational content that helps prospects self-qualify before they ever speak with your sales team.

Podymos capabilities

• Launch planning frameworks: Structured timelines covering messaging development, content creation, and campaign execution
• Sales enablement materials: Battle cards, ROI calculators, and objection handling guides for your commercial team
• Website development: Sites designed to educate HCPs and procurement teams throughout the buying journey

Podymos pros and cons

Pros:

• Exclusive focus on medical devices brings specialized expertise
• Structured methodology helps first-time launchers stay organized
• Offices in both UK and US support transatlantic campaigns

Cons:

• Does not offer full CRM implementation or marketing automation services
• Narrower service scope may require additional partners for paid media or analytics
• Launch-focused model may be less relevant for companies with established device portfolios

3. MedTech Momentum: An outsourced marketing department for device companies

MedTech Momentum is an Orlando-based agency that works only in medical technology, with 150+ device companies served since 2013. Founder Guillaume Viallaneix spent 25 years in the device industry, 15 of them as an executive (Digital Elevator).

The model is a fractional marketing department for device companies that have a sales leader and an engineering team but no marketing hire. That makes it a practical first partner for an early commercial team.

MedTech Momentum capabilities

• Marketing strategy and positioning: Go-to-market planning shaped by device-industry operating experience
• Full-service execution: Content, campaigns and lead generation run as an extension of your team
• Website development: Device websites built for clinical and commercial audiences

MedTech Momentum pros and cons

Pros:

• Medtech-only focus with executive-level industry experience at the top
• Well suited to device companies without an in-house marketing team
• Broad exposure across many device categories

Cons:

• The outsourced-department model fits less well if you already have an in-house team that needs specialist depth
• Smaller scale limits capacity for multi-market or enterprise launches
• Less emphasis on advanced analytics and AI-driven content workflows

4. Supreme Group (Supreme Optimization and Clarity Quest): SEO and paid media for life sciences

Supreme Optimization describes itself as an AI-native life science marketing agency, with scientist-marketers who understand technical audiences. It is also the anchor of Supreme Group, a private equity-backed roll-up. Trinity Hunt Partners took a majority stake in 2023, and the group has since acquired Clarity Quest Marketing, Health+Commerce, BioStrata, Curator24 and Pivot Design (PrivSource). Clarity Quest, which has served medtech and health IT companies since 2001, continues to operate under its own brand (Business Wire).

The acquisitions brought real breadth: SEO, paid media, branding, PR, marketing automation, and benchmarking data from hundreds of life science clients. The group's center of gravity, though, is research tools: reagents, instruments and lab products, where the buyer is a scientist rather than a surgeon, a procurement committee or a hospital value analysis team.

Supreme Group capabilities

• Website design and SEO: Sites built for organic visibility and conversion across scientific and clinical audiences
• Paid media and ABM: Account-based campaigns targeting decision-makers at specific organizations
• Marketing automation and PR: Email nurture, CRM integration and, through Clarity Quest, PR and messaging work

Supreme Group pros and cons

Pros:

• In-house PhD-level scientists understand technical product details
• Benchmarking data across many life science clients helps set performance expectations
• Broad service menu after several acquisitions

Cons:

• Several agencies have joined the group in a short span, so ask which team, and which legacy brand, will actually staff your account
• Private equity ownership tends to favor packaged services and growth targets; confirm how much senior strategy time is in scope
• Research-tools focus means less depth in device launches, and regulatory promotional review isn't a listed specialty

5. EVERSANA INTOUCH: Enterprise-scale commercialization

EVERSANA INTOUCH operates as a large agency network serving pharmaceutical and medtech commercialization needs. The company combines strategy, creative, and execution with AI-powered tools designed for enterprise-scale campaigns.

The network model means access to specialized teams across omnichannel, data analytics, and regulatory compliance. For medical device companies with significant budgets and complex stakeholder landscapes, this scale can be valuable.

EVERSANA INTOUCH capabilities

• Omnichannel strategy: Integrated campaigns spanning HCP, patient, and payer audiences
• Data and analytics: Performance measurement and audience intelligence at enterprise scale
• Global operations: Support for multi-market launches and regional campaigns

EVERSANA INTOUCH pros and cons

Pros:

• Enterprise scale and resources for large commercialization programs
• AI-powered operating model built for life sciences
• Network model provides access to specialized expertise across disciplines

Cons:

• Large agency structure may mean less senior attention on mid-sized accounts
• Network complexity can slow decision-making compared to integrated agencies
• Primary pharmaceutical focus may deprioritize pure-play medical device work

6. Fingerpaint Group: Creative services for life sciences

Fingerpaint Group works across pharmaceutical, biotech, medical device, and animal health categories. The agency positions itself around creative ambition and long-term client partnerships.

The company ranks among the top healthcare agency platforms and serves 95% of the top 20 global pharmaceutical companies. This scale brings resources, though it also means device work competes with larger pharma accounts.

Fingerpaint Group capabilities

• Creative development: Campaign concepting and execution across brand and promotional materials
• Medical affairs: Scientific communications and KOL engagement programs
• Digital and technology: Web development, marketing technology, and data platforms

Fingerpaint Group pros and cons

Pros:

• Creative resources and talent pool for ambitious campaign concepts
• Medical affairs capabilities support clinical and scientific positioning
• Established relationships with major pharmaceutical companies

Cons:

• Pharmaceutical-heavy client roster may mean medical devices receive less focus
• Creative-first positioning may deprioritize performance marketing and analytics
• Larger agency dynamics may reduce flexibility for emerging medtech companies

7. Real Chemistry: Data-driven healthcare network

Real Chemistry operates as a healthcare commercialization partner with analytics at the center. The network has worked with 56 of the top 100 pharmaceutical brands by revenue and employs PhDs, MDs, and PharmDs across therapeutic areas.

The agency offers services from brand building through omnichannel execution, with a particular emphasis on data and insights. Named Healthcare Network of the Year by MM+M, Real Chemistry brings scale and recognition to client engagements.

Real Chemistry capabilities

• Analytics and insights: Data capabilities accessible across all client work and strategic recommendations
• HCP targeting: Audience intelligence and engagement strategies for clinical decision-makers, including KOL digital engagement programs
• Launch planning: Pre-launch through commercialization support across therapeutic areas

Real Chemistry pros and cons

Pros:

• Industry recognition and awards demonstrate creative and strategic capabilities
• In-house scientific expertise across multiple therapeutic areas
• Global footprint supports international launch campaigns

Cons:

• Network scale may mean variable team quality across engagements
• Primary pharmaceutical orientation may deprioritize device-specific needs
• Premium positioning may not fit smaller medtech company budgets

8. Icovy: Boutique agency for emerging medtech

Icovy focuses specifically on medical device and medtech marketing. The boutique agency model offers closer client relationships and direct access to senior strategists. For emerging device companies and startups, this can mean more tailored attention.

The agency's medtech-only focus ensures the team stays current on device-specific regulatory requirements and market dynamics. This specialization comes with trade-offs in scale and service breadth.

Icovy capabilities

• Brand strategy: Positioning and messaging development for medical device launches
• Digital marketing: Website development, SEO, and lead generation campaigns
• Content creation: Educational materials for HCPs and clinical stakeholders

Icovy pros and cons

Pros:

• Exclusive medtech focus brings specialized knowledge
• Boutique model offers senior-level attention and faster decisions
• Suited to emerging companies and startup budgets

Cons:

• Smaller team limits capacity for large-scale campaigns
• May need additional partners for advanced analytics or marketing automation
• Less established track record compared to larger agencies

Comparison table: Medical device marketing agencies for 2026

What should you look for in a medical device marketing agency?

Choosing the right agency depends on where you are in your commercial journey. If you're preparing for a first US launch, prioritize partners with regulatory content expertise and FDA submission experience. You need an agency that can create promotional materials your medical-legal team will approve without endless revision cycles. Knowing whether your device sits on a 510(k) or PMA pathway shapes the regulatory work significantly.

For established device portfolios, focus on omnichannel capabilities and measurement infrastructure. Your agency should help you track which campaigns drive qualified leads and how those leads convert through the sales cycle. Integration with your CRM becomes critical for connecting marketing spend to revenue outcomes. If you're feeling the squeeze between top-of-funnel interest and closed pipeline, our mid-funnel playbook for healthcare B2B is worth a read.

Consider your internal resources when evaluating agency scope. A full-stack partner reduces coordination overhead by handling strategy through execution. If you have strong internal capabilities in certain areas, a more specialized agency might fill specific gaps without duplicating what you already do well.

One more question worth asking any agency: who owns it, and has it recently merged with others? Consolidation is common in healthcare marketing, and the team that pitches you isn't always the team that runs your account.

Not sure which gaps are yours? Walk through your scope with us →

How do you evaluate ROI from medical device marketing?

Measuring marketing ROI in medtech requires patience and the right attribution model. Device sales cycles often span months, involve multiple stakeholders, and include steps like clinical evaluations and procurement committee reviews. Simple last-touch attribution misses most of the marketing influence.

Start by defining leading indicators that signal pipeline health. These might include qualified leads from HCPs, clinical evaluation requests, or engagement with educational content. Track these metrics alongside revenue to understand which marketing activities drive meaningful commercial outcomes. For analytics that hold up under HIPAA scrutiny, see our guide to HIPAA-compliant GA4 setup.

Whichever agency you choose, ask them to show you this measurement layer before you sign: how they connect campaigns to CRM stages, and what the dashboard you'll see each month looks like.

Where XDS fits, and where it doesn't

XDS is a strong fit for medtech companies preparing a US launch or scaling a regulated device portfolio, where one team needs to handle regulatory-ready content, the website, CRM and measurement together. The AI-driven approach to content structuring also matters as AI search reshapes how HCPs find information, which means structuring content for Generative Engine Optimization (GEO) and adapting to how AEO and GEO are changing B2B SEO for medtech and biotech.

It's a weaker fit in a few cases, and other agencies on this list cover them better:

• Simultaneous multi-market global launches: network agencies like EVERSANA INTOUCH or Real Chemistry bring more in-market teams.
• Device companies with no marketing hire yet: MedTech Momentum's outsourced-department model is built for that.
• Very early-stage startups on tight budgets: a boutique like Icovy may suit a first, narrow program.
• A structured launch playbook with a UK base: Podymos is built around exactly that.

If you're weighing XDS against any of these, get in touch and we'll give you a straight answer on fit.

FAQs about medical device marketing agencies

What makes a medical device marketing agency different from a general healthcare agency?

Medical device agencies understand the regulatory environment specific to devices, including FDA 510(k) and PMA pathways, OPDP promotional review, and fair balance requirements. General healthcare agencies may lack depth in device-specific compliance and HCP engagement strategies.

How long before a device launch should you engage a marketing agency?

Plan to engage your agency nine to twelve months before anticipated approval. That allows time for brand strategy, messaging testing, content creation, and sales enablement preparation, so you have momentum from the first day of market entry.

What should you include in a medical device marketing RFP?

Include your device category, target audiences (HCPs, patients, procurement), regulatory status, launch timeline, and specific capability needs. Ask agencies about their regulatory content experience, measurement approach, relevant case studies, ownership, and who will staff your account day to day.

How do medical device marketing agencies handle FDA compliance?

Experienced agencies build compliance into their process from the start. That means structuring content for medical-legal review, including required fair balance, and documenting claims with approved references, so materials move through review efficiently.

What's the typical budget range for medical device marketing services?

Budgets vary significantly based on scope, channels, and launch complexity. A structured launch program in a single region typically requires meaningful investment to cover strategy, content, web development, and campaign execution. A good agency will help you prioritize the highest-impact activities within your budget.